Zimeldine Hydrochloride

CHEMBL2355333 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
408.2 g/mol
LogP
Phase
4

Zimeldine hydrochloride is the hydrochloride salt of zimeldine, the first SSRI developed, which selectively inhibits the serotonin transporter to increase synaptic serotonin availability for antidepressant effects. It was withdrawn from the market due to cases of Guillain-Barré syndrome and other hypersensitivity-related neurological adverse events. Its development and withdrawal provided critical lessons for the subsequent design and safety monitoring of the SSRI drug class.

分子量

408.2000 g/mol

TPSA

17.10 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl.O

InChI

InChI=1S/C16H17BrN2.2ClH.H2O/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13;;;/h3-10,12H,11H2,1-2H3;2*1H;1H2/b16-9-;;;

Molecular Formula

C16H21BrCl2N2O

HBD / HBA

3 / 3

回転可能結合数

4

重原子数

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Zimeldine hydrochloride is the hydrochloride salt of zimeldine, the first SSRI developed, which selectively inhibits the serotonin transporter to increase synaptic serotonin availability for antidepressant effects. It was withdrawn from the market due to cases of Guillain-Barré syndrome and other hypersensitivity-related neurological adverse events. Its development and withdrawal provided critical lessons for the subsequent design and safety monitoring of the SSRI drug class.

Yes, Zimeldine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2355333. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6420041. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.